Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
602
datasets available to search
ShareScore release 0.9.0
Dataset results
602 results for “natural killer cell”
Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell Lymphoma
ClinicalTrials.gov study NCT04423536. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
ClinicalTrials.gov study NCT00877110. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
ClinicalTrials.gov study NCT00640796. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer(NK) Cell Therapy for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05601466. IPD Sharing: NO. Countries: 1. Publications: 0.
Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)
ClinicalTrials.gov study NCT04395092. IPD Sharing: NO. Countries: 1. Publications: 0.
Natural Killer (NK) Cells Following Bariatric Surgery
ClinicalTrials.gov study NCT02732535. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Autologous Natural Killer Cells in Subjects With Plaque Psoriasis
ClinicalTrials.gov study NCT03894579. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia
ClinicalTrials.gov study NCT06702098. IPD Sharing: YES. Countries: 1. Publications: 0.
Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL
ClinicalTrials.gov study NCT03524235. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01787474. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
ClinicalTrials.gov study NCT05726682. IPD Sharing: YES. Countries: 0. Publications: 0.
Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients
ClinicalTrials.gov study NCT00846157. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Autologous Natural Killer Cells in Multiple Myeloma
ClinicalTrials.gov study NCT04558853. IPD Sharing: NO. Countries: 1. Publications: 0.
Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2
ClinicalTrials.gov study NCT00896701. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
ClinicalTrials.gov study NCT05400122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05580601. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Uterine Natural Killer (uNK) Cell Expression in Patients With Repeated ICSI Failures: A Multicenter Cohort Study
ClinicalTrials.gov study NCT04867759. IPD Sharing: YES. Countries: 1. Publications: 0.
Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06044506. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
ClinicalTrials.gov study NCT00336063. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
ClinicalTrials.gov study NCT05588453. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.